These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 824205)

  • 1. Passive immunity against pseudomonas sepsis during granulocytopenia.
    Harvath L; Andersen BR; Amirault HJ
    Infect Immun; 1976 Nov; 14(5):1151-5. PubMed ID: 824205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of type-specific and non-type-specific pseudomonas vaccine for treatment of pseudomonas sepsis during granulocytopenia.
    Harvath L; Andersen BR
    Infect Immun; 1976 Apr; 13(4):1139-43. PubMed ID: 819373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined pre-immunization and granulocyte transfusion therapy for treatment of pseudomonas septicemia in neutropenic dogs.
    Harvath L; Andersen BR; Zander AR; Epstein RB
    J Lab Clin Med; 1976 May; 87(5):840-7. PubMed ID: 1270891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of lipopolysaccharide-induced protection against pseudomonas sepsis in granulocytopenic mice.
    Tegtmeier BR; Andersen BR
    Rev Infect Dis; 1983; 5 Suppl 5():S963-70. PubMed ID: 6419318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice.
    Powderly WG; Pier GB; Markham RB
    J Clin Invest; 1986 Aug; 78(2):375-80. PubMed ID: 2426306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental pneumonia due to Pseudomonas aeruginosa in leukopenic dogs: prolongation of survival by combined treatment with passive antibody to Pseudomonas and granulocyte transfusions.
    Kazmierowski JA; Reynolds HY; Kauffman JC; Durbin WA; Graw RG; Devlin HB
    J Infect Dis; 1977 Mar; 135(3):438-46. PubMed ID: 403242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Pseudomonas aeruginosa antigenemia in granulocytopenic rabbits by radiommunoassay.
    Kohler RB; Wheat LJ; White A
    J Clin Microbiol; 1980 Jul; 12(1):39-43. PubMed ID: 6775008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
    Lieberman MM; McKissock DC; Wright GL
    Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
    Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
    FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of type-specific active immunization on the development and progression of experimental Pseudomonas aeruginosa endocarditis.
    Archer GL; Johnston JL
    Infect Immun; 1979 Apr; 24(1):167-73. PubMed ID: 110689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of liposomal cefoperazone against Pseudomonas aeruginosa in a granulocytopenic mouse model of acute lung infection.
    Di Rocco PH; Nacucchio MC; Sordelli DO; Mancuso F; Hooke AM
    Infection; 1992; 20(6):360-4. PubMed ID: 1293058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polyvalent human gamma-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection.
    Fisher MW
    J Infect Dis; 1977 Aug; 136 Suppl():S181-5. PubMed ID: 70492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa infections: persisting problems and current research to find new therapies.
    Ann Intern Med; 1975 Jun; 82(6):819-31. PubMed ID: 806246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
    Pennington JE; Small GJ
    J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of antioxidant treatment in pneumonia of granulocytopenic rats].
    Xu JF; Qu JM; He LX; Zhang J; Li ZZ; Chen XH; Pan J; Li HP
    Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):853-6. PubMed ID: 15634548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
    Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR
    Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nonagglutinating antibody in the protracted immunity of vaccinated mice to Pseudomonas aeruginosa infection.
    Moody MR; Kessel RW; Young VM; Fiset P
    Infect Immun; 1978 Sep; 21(3):905-13. PubMed ID: 101467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.
    Pavlovskis OR; Pollack M; Callahan LT; Iglewski BH
    Infect Immun; 1977 Dec; 18(3):596-602. PubMed ID: 412786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
    Cui Z; Han D; Sun X; Zhang M; Feng X; Sun C; Gu J; Tong C; Lei L; Han W
    Appl Microbiol Biotechnol; 2015 Jan; 99(2):667-80. PubMed ID: 25381907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.